ChristianaCare’s Gene Editing Institute has launched DECODR, Inc., a new for‑profit company created to expand access to one of the world’s leading software tools to evaluate the effectiveness of ...

Planned Interim Futility Analysis from Pivotal Phase 2 ALPHA3 Trial Supports Cemacabtagene Ansegedleucel’s (Cema-Cel) Potential as an Outpatient, ...

Allogeneic hematopoietic cell transplantation (alloHCT) using tremtelectogene empogeditemcel (trem-cel), a CRISPR–Cas9–edited ...

CRISPR-edited tumor-infiltrating lymphocytes are emerging as a promising alternative to CAR T-cell therapy for solid cancers.

The market remained flat over the last week but is up 25% over the past year, with earnings forecast to grow by 17% annually. In light of these conditions, identifying stocks with strong financials ...

Fivetran, the data foundation for AI, today announced plans to become steward of the Great Expectations open source community and GX Core project, supporting the continued development of one of the ...

Infraway's L1 Lower Back Wearable Heat Pad combines Far Infrared (FIR) and topical heat to enhance mobility, support recovery, and facilitate warm-up. Unlike competitor products, Infraway is discreet ...

Pumpkinseed founders Jennifer Dionne, Jack Hu, and Nhat Vu discuss their nanophotonic chip platform that promises label-free, ...

I n December 2020, mRNA vaccines leapt into the limelight as a response to the COVID-19 pandemic. To date, millions of people ...